[1]
Cathomas, R., Schardt, J., Pless, M., Llado, A., Mach, N., Riklin, C., Haefeli, J., Fear, S. and Stenner, F. 2020. Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss Medical Weekly. 150, 1920 (May 2020), w20223. DOI:https://doi.org/10.4414/smw.2020.20223.